1. Home
  2. BOW vs TBPH Comparison

BOW vs TBPH Comparison

Compare BOW & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bowhead Specialty Holdings Inc.

BOW

Bowhead Specialty Holdings Inc.

HOLD

Current Price

$22.37

Market Cap

913.3M

Sector

Finance

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$14.76

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOW
TBPH
Founded
2020
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
913.3M
1.0B
IPO Year
2024
2013

Fundamental Metrics

Financial Performance
Metric
BOW
TBPH
Price
$22.37
$14.76
Analyst Decision
Buy
Strong Buy
Analyst Count
7
5
Target Price
$34.29
$18.50
AVG Volume (30 Days)
218.4K
830.5K
Earning Date
05-05-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
23.26
279.13
EPS
1.59
2.06
Revenue
$551,589,000.00
$15,386,000.00
Revenue This Year
$21.14
$9.51
Revenue Next Year
$19.15
N/A
P/E Ratio
$13.63
$16.23
Revenue Growth
29.58
N/A
52 Week Low
$21.21
$7.90
52 Week High
$42.29
$21.03

Technical Indicators

Market Signals
Indicator
BOW
TBPH
Relative Strength Index (RSI) 40.21 40.20
Support Level $22.15 $13.41
Resistance Level $26.17 $15.22
Average True Range (ATR) 0.82 0.44
MACD -0.13 0.14
Stochastic Oscillator 29.94 89.80

Price Performance

Historical Comparison
BOW
TBPH

About BOW Bowhead Specialty Holdings Inc.

Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: